LBPH Longboard Pharmaceuticals Inc

Price (delayed)

$36.83

Market cap

$1.43B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.24

Enterprise value

$1.38B

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Longboard was formed in January 2020 by Arena to advance a portfolio of ...

Highlights
The quick ratio has soared by 197% YoY
The EPS is up by 13% year-on-year and by 6% since the previous quarter
The net income is down by 27% year-on-year and by 6% since the previous quarter

Key stats

What are the main financial stats of LBPH
Market
Shares outstanding
38.88M
Market cap
$1.43B
Enterprise value
$1.38B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.23
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$57.95M
EBITDA
-$57.95M
Free cash flow
-$52.95M
Per share
EPS
-$2.24
Free cash flow per share
-$1.5
Book value per share
$8.71
Revenue per share
$0
TBVPS
$9.28
Balance sheet
Total assets
$327.67M
Total liabilities
$13.96M
Debt
$3.98M
Equity
$313.71M
Working capital
$313.15M
Liquidity
Debt to equity
0.01
Current ratio
31.43
Quick ratio
31.2
Net debt/EBITDA
0.87
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-46%
Return on equity
-49.9%
Return on invested capital
-64%
Return on capital employed
-18.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LBPH stock price

How has the Longboard Pharmaceuticals stock price performed over time
Intraday
-3.99%
1 week
5.62%
1 month
93.94%
1 year
414.39%
YTD
510.78%
QTD
36.26%

Financial performance

How have Longboard Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$62.92M
Net income
-$57.95M
Gross margin
N/A
Net margin
N/A
Longboard Pharmaceuticals's operating income has decreased by 33% YoY and by 11% from the previous quarter
The net income is down by 27% year-on-year and by 6% since the previous quarter

Growth

What is Longboard Pharmaceuticals's growth rate over time

Valuation

What is Longboard Pharmaceuticals stock price valuation
P/E
N/A
P/B
4.23
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 13% year-on-year and by 6% since the previous quarter
The P/B is 51% above the last 4 quarters average of 2.8

Efficiency

How efficient is Longboard Pharmaceuticals business performance
The ROIC has soared by 58% from the previous quarter and by 27% YoY
LBPH's return on equity is up by 49% since the previous quarter and by 21% year-on-year
The ROA has grown by 46% from the previous quarter and by 19% YoY

Dividends

What is LBPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LBPH.

Financial health

How did Longboard Pharmaceuticals financials performed over time
The quick ratio has soared by 197% YoY
Longboard Pharmaceuticals's current ratio has surged by 188% YoY
The company's debt is 99% lower than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.